Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Cited by (1,004)

Items 401–500 of 1,004

1. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
   André F. Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, Harjot Kaur Singh, Ayana E. Morales, Robert Andrew Desimone, Grant B. Ellsworth, Rosemary Soave, Shashi N. Kapadia, Kohta Saito et al. · 2020 · Life Science Alliance
2. Manipulation of ACE2 expression in COVID-19
   Farhan Chaudhry, Sergio Lavandero, Xiang Xie, Basera Sabharwal, Ying‐Ying Zheng, Ashish Adrian Correa, Jagat Narula, Phillip David Levy · 2020 · Open Heart
3. Do cross-reactive antibodies cause neuropathology in COVID-19?
   Jakob Kreye, S. Momsen Reincke, Harald Prüß · 2020 · Nature reviews. Immunology
4. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives
   Iqbal Mahmud, Timothy J. Garrett · 2020 · Journal of the American Society for Mass Spectrometry
5. Immunotherapeutic approaches to curtail COVID-19
   Hajar Owji, Manica Negahdaripour, Nasim Hajighahramani · 2020 · International Immunopharmacology
6. Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
   Alpana Waghmare, Maheen Z. Abidi, Michael Boeckh, Roy F. Chemaly, Sanjeet Dadwal, Zeinab El Boghdadly, Mini Kamboj, Genovefa A. Papanicolaou, Steven A. Pergam, Zainab Shahid · 2020 · Transplantation and Cellular Therapy
7. Infectious disease-associated encephalopathies
   Maria Carolina Barbosa‐Silva, Maiara N. Lima, Denise Battaglini, Chiara Robba, Paolo P. Pelosi, Patrícia R. M. Rocco, Tatiana Maron‐Gutierrez · 2021 · Critical Care
8. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
   Aljosja Rogiers, Inês Pires da Silva, Chiara Tentori, Carlo Alberto Tondini, Joseph M. Grimes, Megan H. Trager, Sharon H. Nahm, Leyre Zubiri, Michael P. Manos, Peter J. Bowling et al. · 2021 · Journal for ImmunoTherapy of Cancer
9. Endothelial cells and SARS-CoV-2: An intimate relationship
   Lucas Cunha Barbosa, Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, Luciane Rosário, Valéria Pereira Ferrer · 2021 · Vascular Pharmacology
10. Hospitalised COVID-19 patients of the Mount Sinai Health System: a retrospective observational study using the electronic medical records
    Zichen Wang, Amanda B. Zheutlin, Yu-Han Kao, Kristin L. Ayers, Susan J. Gross, Patricia Kovatch, Sharon Nirenberg, Alexander W. Charney, Girish N. Nadkarni, Jessica K. De Freitas et al. · 2020 · BMJ Open
11. Severe COVID-19: what have we learned with the immunopathogenesis?
    Bruno Bordallo Corrêa, Mozart Bellas Rodrigues, Arthur Fernandes Cortez, Matheus Vieira, Marcelo M. Pinheiro · 2020 · Revista Brasileira de Reumatologia
12. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study
    Alessandro Maria Vannucchi, Benedetta Sordi, A Morettini, Carlo Nozzoli, Loredana Poggesi, Filippo Pieralli, Alessandro Bartoloni, Alessandro Atanasio, Filippo Miselli, Chiara Paoli et al. · 2020 · Leukemia
13. The COVID-19 Drug and Gene Set Library
    Maxim V. Kuleshov, Daniel J. Stein, Daniel J. B. Clarke, Eryk Kropiwnicki, Kathleen M. Jagodnik, Alon Bartal, John Erol Evangelista, Jason Hom, Minxuan Cheng, Allison Bailey et al. · 2020 · Patterns
14. The RECOVERY Platform
    S. Normand · 2020 · New England Journal of Medicine
15. Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature
    Catharina Korsukewitz, Stephen Reddel, Amit Bar‐Or, Heinz Wiendl · 2020 · Nature Reviews Neurology
16. Clinical characteristics and manifestations in older patients with COVID-19
    Chenchen Wei, Ya Liu, Yapeng Liu, Kai Zhang, Dezhen Su, Ming Zhong, Meng Xiao · 2020 · BMC Geriatrics
17. Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
    Muhammad Fayyaz ur Rehman, Shahzaib Akhter, Aima Iram Batool, Zeliha Selamoğlu, Мustafa Sevindik, Rida Eman, Muhammad Mustaqeem, Muhammad Safwan Akram, Fariha Kanwal, Changrui Lu et al. · 2021 · Antibiotics
18. Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19
    Anas Baiou, Abdurrahmaan Ali Suei Elbuzidi, Dana Bakdach, Ahmed Zaqout, Khaled Mohamed S Alarbi, Awadh Bintaher, M.M.B. Ali, Anam Elarabi, G.A.M. Ali, Joanne Daghfal et al. · 2021 · Journal of Hospital Infection
19. NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors
    Mahesh Kandasamy · 2021 · Naunyn-Schmiedeberg s Archives of Pharmacology
20. Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial
    Meenu Bajpai, Suresh Kumar, Ashish Maheshwari et al. · 2020 · medRxiv
21. COVID-19 Therapeutic Options Under Investigation
    Malak Kaddoura, Malak Al Ibrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, Salame Haddad, Ali Hussein Eid, Hassan Zaraket · 2020 · Frontiers in Pharmacology
22. Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
    Francesco Salton, Paola Confalonieri, Giuseppina Campisciano, Rossella Cifaldi, Clara Rizzardi, Daniele Generali, Riccardo Pozzan, Stefano Tavano, Chiara Bozzi, Giulia Lapadula et al. · 2022 · Journal of Clinical Medicine
23. Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS
    Aartik A. Sarma, Stephanie A. Christenson, Ashley Byrne, Eran Mick, Angela Oliveira Pisco, Catherine DeVoe, Thomas J. Deiss, Rajani Ghale, Beth Shoshana Zha, Alexandra Tsitsiklis et al. · 2021 · Nature Communications
24. Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update
    Deepika Sankaran, Natasha A. Nakra, Ritu Cheema, Dean A. Blumberg, Satyan Lakshminrusimha · 2021 · NeoReviews
25. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
    Stephen A. Klassen, Jonathon W. Senefeld, Katherine A. Senese, Patrick W. Johnson, Chad C. Wiggins, Sarah E. Baker, Noud van Helmond, Katelyn A. Bruno, Liise‐anne Pirofski, Shmuel Shoham et al. · 2021 · Frontiers in Medicine
26. Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics
    Rachael Batabyal, Nathaniel Freishtat, Elaise Hill, Muhammad Rehman, Robert J. Freishtat, Ioannis Koutroulis · 2021 · International Journal of Obesity
27. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
    Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, Adriano Giorgio Rossi, Nicole Brace, Paul Aidan Cahill, Sandra M MacRury, Jun Wei, Ian L. Megson · 2021 · Frontiers in Cardiovascular Medicine
28. Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System
    Kathleen M. Andersen, Hemalkumar B. Mehta, Natasha Palamuttam, Daniel E. Ford, Brian Thomas Garibaldi, Paul G. Auwaerter, Jodi B Segal, G. Caleb Alexander · 2021 · Clinical Infectious Diseases
29. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study
    Michele Bartoletti, Lorenzo Marconi, Luigia Scudeller et al. · 2020 · Clinical Microbiology and Infection
30. Evidence-based medicine and COVID-19: what to believe and when to change
    Simon David Carley, Daniel Edward Horner, Richard M. Body, Kevin C Mackway-Jones · 2020 · Emergency Medicine Journal
31. High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients
    Iglesias-Julián, Enrique, López-Veloso, María, de-la-Torre-Ferrera, Noelia, Barraza-Vengoechea, Julio Cesar, Delgado-López, Pedro David, Colazo-Burlato, María, Ubeira-Iglesias, Marta, Montero-Baladía, Miguel, Lorenzo-Martín, Andrés, Minguito-de-la-Iglesia, Javier et al. · 2020 · Journal of Autoimmunity
32. An overview on the treatments and prevention against COVID-19
    Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, Fatemeh Beiraghdar, Abolfazl Akbarzadeh, Vahideh Tarhriz, Hassan Mellatyar · 2023 · Virology Journal
33. COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea
    Moon Seong Baek, Min‐Taek Lee, Won‐Young Kim, Jae Chol Choi, Sun‐Young Jung · 2021 · PLoS ONE
34. Covid-19 and development of heart failure: mystery and truth
    Hope Onohuean, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Safaa Y. Qusti, Eida Mohammed Alshammari, Gaber El‐Saber Batiha · 2021 · Naunyn-Schmiedeberg s Archives of Pharmacology
35. Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency
    Thomas Magg, Tsubasa Okano, Lars M. König, Daniel F. R. Boehmer, Samantha L. Schwartz, Kento Inoue, Jennifer R. Heimall, Francesco Licciardi, Julia Ley‐Zaporozhan, Ronald M. Ferdman et al. · 2021 · Science Immunology
36. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
    Μaria Dalamaga, Gerasimos Socrates Christodoulatos, Ιrene Karampela, Natalia G. Vallianou, Caroline Margaret Apovian · 2021 · Current Obesity Reports
37. Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19—Experience and Lessons from the SARS Epidemic
    Shenqi Zhang, Chengbin Wang, Lei Shi, Qingyun Xue · 2021 · Drug Design Development and Therapy
38. Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
    Shaolei Ma, Changsheng Xu, Shijiang Liu, Xiaodi Sun, Renqi Li, Mingjie Mao, Shanwu Feng, Xian Wang · 2021 · Signal Transduction and Targeted Therapy
39. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm
    Alice S. Chau, Andrew G. Weber, Naomi I. Maria, Sonali Narain, Audrey Liu, Negin Hajizadeh, Prashant Malhotra, Ona Bloom, Galina S. Marder, Blanka M. Kaplan · 2020 · Arthritis & Rheumatology
40. Convalescent plasma for covid-19
    L. Estcourt, D. Roberts · 2020 · British medical journal
41. The “Infodemic” of COVID‐19
    Daniel H. Solomon, Richard Bucala, Mariana J. Kaplan, Peter Andrija Nigrovic · 2020 · Arthritis & Rheumatology
42. The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review
    Avi Gurion Kaye, Robert Siegel · 2020 · PeerJ
43. Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread
    Shubhankar S. Ambike, Cho‐Chin Cheng, Martin Feuerherd, Stoyan Velkov, Domizia Baldassi, Suliman Qadir Afridi, Diana Porras-Gonzalez, Xin Chuan Wei, Philipp Hagen, Nikolaus Kneidinger et al. · 2021 · Nucleic Acids Research
44. Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort
    Magunia, Harry, Lederer, Simone, Verbuecheln, Raphael, Gilot, Bryant Joseph, Koeppen, Michael, Haeberle, Helene A., Mirakaj, Valbona, Hofmann, Pascal, Marx, Gernot, Bickenbach, Johannes et al. · 2021 · Critical Care
45. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone
    Olumayokun A. Olajide, Victoria U. Iwuanyanwu, Izabela Lepiarz‐Raba, Alaa A Al‐Hindawi · 2021 · Inflammation
46. Anti-IL6 treatment of serious COVID-19 disease
    L. Castelnovo, A. Tamburello, A. Lurati et al. · 2021 · Medicine
47. Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection: a Systematic Review with Meta-analysis
    Mangla Sood, Seema Sharma, Ishaan Sood, Kavya Sharma, Ashlesha Kaushik · 2021 · SN Comprehensive Clinical Medicine
48. Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial
    Fatemeh Roozbeh, Majid Saeedi, Reza Alizadeh‐Navaei, Akbar Hedayatizadeh‐Omran, Shahin Merat, Hannah Wentzel, Jacob Levi, Andrew Martin Hill, Amir Shamshirian · 2020 · Journal of Antimicrobial Chemotherapy
49. High‐dose methylprednisolone in nonintubated patients with severe COVID‐19 pneumonia
    Aikaterini Papamanoli, Jeanwoo Yoo, Prabhjot K. Grewal, William Predun, Jessica Hotelling, Robin Jacob, Azad Mojahedi, Hal A. Skopicki, Mohamed Mansour, Luis A. Marcos et al. · 2020 · European Journal of Clinical Investigation
50. Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19
    Manuel Rubio‐Rivas, Xavier Corbella, José María Mora‐Luján, José Loureiro-Amigo, Almudena López Sampalo, Carmen Yera Bergua, Pedro Jesús Esteve Atiénzar, Díez García F, Ruth González Ferrer, Susana Plaza Canteli et al. · 2020 · Journal of Clinical Medicine
51. Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations
    Francisco Mosquera-Yuqui, Nicolas Lopez-Guerra, Eduardo A. Moncayo · 2020 · Journal of Biomolecular Structure and Dynamics
52. A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection
    Gülali Aktaş · 2020 · Experimental Biomedical Research
53. COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm
    Patrick C. Bradshaw, William A. Seeds, Alexandra C. Miller, Vikrant R. Mahajan, William M. Curtis · 2020 · Oxidative Medicine and Cellular Longevity
54. SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry
    Amy Houghton Attaway, Joe Zein, Umur Sevket Hatipoglu · 2020 · EClinicalMedicine
55. Effects of Environmental Factors on Severity and Mortality of COVID-19
    Domagoj Kifer, Dario Bugada, Judit Villar-García, Ivan Gudelj, Cristina Menni, Carole H. Sudre, Frano Vučković, Ivo Ugrina, Ferdinando Luca Lorini, Margarita Posso et al. · 2021 · Frontiers in Medicine
56. Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis
    Partha Biswas, Mohammad Mehedi Hasan, Dipta Dey, Ana Carla dos Santos Costa, Shakil Ahmed Polash, Shabana Bibi, Nadim Ferdous, Md. Abu Kaium, MD. Hasanur Rahman, Fardin Kamal Jeet et al. · 2021 · Environmental Science and Pollution Research
57. Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate
    Puja Mehta, David C. Fajgenbaum · 2021 · Current Opinion in Rheumatology
58. Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study
    Inès Gragueb-Chatti, Alexandre Lopez, Dany Hamidi, Christophe Guervilly, Anderson Loundou, Florence Daviet, Nadim Cassir, Laurent Papazian, Jean-Marie Forel, Marc Léone et al. · 2021 · Annals of Intensive Care
59. Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection
    Sophie A. Clarke, Maria Phylactou, Bijal Patel, Edouard Mills, Beatrice Muzi, Chioma N. Izzi‐Engbeaya, Sirazum Choudhury, Bernard Chong Eu Khoo, Karim M. Meeran, Alexander N. Comninos et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
60. COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs
    Alessandra Bartoli, Filippo Gabrielli, Tatiana Alicandro, Fabio Nascimbeni, Pietro Andreoné · 2021 · Internal and Emergency Medicine
61. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects
    Sree Pooja Varahachalam, Behnaz Lahooti, Masoumeh Chamaneh, Sounak Bagchi, Tanya Chhibber, Kevin Morris, Joe F. Bolanos, Nam‐Young Kim, Ajeet Kumar Kaushik · 2021 · International Journal of Nanomedicine
62. Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients
    A. Rodríguez-Molinero, C. Gálvez-Barrón, A. Miñarro et al. · 2020 · PLoS ONE
63. Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects
    Arash Arashkia, Somayeh Jalilvand, Nasir Mohajel, Atefeh Afchangi, Kayhan Azadmanesh, ‪Mostafa Salehi-Vaziri, Mehdi Fazlalipour, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Seyed Dawood Mousavi Nasab et al. · 2020 · Reviews in Medical Virology
64. Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
    Francesco Menzella, Matteo S. Fontana, Carlo Salvarani, Marco Massari, Patrizia Ruggiero, Chiara Scelfo, Chiara Barbieri, Claudia Castagnetti, Chiara Catellani, Giorgia Gibellini et al. · 2020 · Critical Care
65. Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)
    Antonio F. Saad, Lucy C. Chappell, George Robert Saade, Luis Diego Pacheco · 2020 · Obstetrics and Gynecology
66. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials
    Rohan Chakraborty, Suhel Parvez · 2020 · Biochemical Pharmacology
67. Antimicrobial Consumption among 66 Acute Care Hospitals in Catalonia: Impact of the COVID-19 Pandemic
    Santiago Grau, Sergi Hernández, Daniel Echeverría-Esnal, Alexander Almendral, Ricard Ferrer, Enrique Limón Cáceres, Juan Pablo Horcajada, on behalf of the Catalan Infection Control Antimicrobial Stewardship Program (VINCat-PROA) · 2021 · Antibiotics
68. Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19
    Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Grace Chung-Yan Lui, Viola Chi‐Ying Chow, Yee‐Kit Tse, Vicki Wing‐Ki Hui, Lilian Yan Liang, Henry Lik‐Yuen Chan, David S.C. Hui, Grace Lai‐Hung Wong · 2021 · Hepatology
69. Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study
    April M Jorge, Kristin M. D’Silva, Andrew Cohen, Zachary Scott Wallace, Natalie McCormick, Yuqing Zhang, Hyon K. Choi · 2020 · The Lancet Rheumatology
70. Complement cascade in severe forms of COVID‐19: Recent advances in therapy
    Nassima Chouaki Benmansour, Julien Carvelli, Éric Vivier · 2021 · European Journal of Immunology
71. New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
    Muneerah M Aleissa, Emily A. Silverman, Luisa M. Paredes Acosta, Cameron T. Nutt, Aaron G. Richterman, Francisco M. Marty · 2020 · Antimicrobial Agents and Chemotherapy
72. Treatment of immunocompromised COVID‐19 patients with convalescent plasma
    Monica Fung, Ashokan Nambiar, Suchitra Pandey et al. · 2020 · Transplant Infectious Disease
73. COVID-19 clinical trials: learning from exceptions in the research chaos
    K. Tikkinen, R. Malekzadeh, M. Schlegel · 2020 · Nature Medicine
74. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
    Christiana Kartsonaki, John Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abi Beane, Lucille Hellen Blumberg, Fernando A. Bozza, Tessa Broadley, Aidan J. C. Burrell, Gail Carson et al. · 2023 · International Journal of Epidemiology
75. Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
    Andrew Martin Hill, Ahmed Abdulamir, Sabeena Ahmed, Asma Asghar, Olufemi Emmanuel Babalola, Rabia Basri, Carlos Chaccour, Aijaz Zeeshan Khan Chachar, Abu Tauib Mohammed Chowdhury, Ahmed Elgazzar et al. · 2021 · Open Forum Infectious Diseases · Retracted
76. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
    Prats-Uribe, Albert, Sena, Anthony G, Lai, Lana Yin Hui, Ahmed, Waheed-Ul-Rahman, Alghoul, Heba, Alser, Osaid, Alshammari, Thamir M, Areia, Carlos, Carter, William, Casajust, Paula et al. · 2021 · BMJ
77. The Global Case-Fatality Rate of COVID-19 Has Been Declining Since May 2020
    Mohammad Nayeem Hasan, Najmul Haider, Florian L. Stigler, Rumi Ahmed Khan, David McCoy, Alimuddin I. Zumla, Richard Anthony Kock, Md. Jamal Uddin · 2021 · American Journal of Tropical Medicine and Hygiene
78. Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
    Abdullahi Rabiu Abubakar, Ibrahim Haruna Sani, Brian Godman, Santosh Kumar, Salequl Islam, Iffat Jahan, Mainul Haque · 2020 · Infection and Drug Resistance
79. Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
    Yogiraj Ray, Shekhar Ranjan Paul, P. Bandopadhyay et al. · 2020 · medRxiv
80. Trajectories of Hospitalization in COVID-19 Patients: An Observational Study in France
    Pierre‐Yves Boëlle, Tristan Delory, Xavier Maynadier, Cécile Janssen, Renaud Piarroux, Marie Pichenot, Xavier Lemaire, N. Baclet, Pierre Weyrich, Hugues Melliez et al. · 2020 · Journal of Clinical Medicine
81. Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis
    Haytham Tlayjeh, Olaa H. Mhish, Mushira A. Enani, Alya Alruwaili, Rana Tleyjeh, Lukman Thalib, Leslie C. Hassett, Yaseen M. Arabi, Tarek Seifaw Kashour, Imad M. Tleyjeh · 2020 · Journal of Infection and Public Health
82. Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis
    Michael Putman, Yu Pei Eugenia Chock, Herman H. Y. Tam, Alfred H.J. Kim, Sebastian Eduardo Sattui, Françis Berenbaum, Maria I. Danila, Peter Korsten, Catalina Sánchez-Álvarez, Jeffrey A. Sparks et al. · 2020 · Arthritis & Rheumatology
83. Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
    Miguel Ángel Martı́nez · 2021 · Frontiers in Immunology
84. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state
    Antonio Vitiello, Francesco Ferrara · 2021 · Respiratory Medicine
85. Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study
    Guangdi Li, Yacong Liu, Xixi Jing, Yali Wang, Miao Miao, Tao Li, Zhiguo Zhou, Yuanlin Xie, Yaxiong Huang, Jianhua Lei et al. · 2020 · Aging
86. Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
    Daniel Camprubí-Ferrer, Alex Almuedo-Riera, Helena Martí-Soler, Àlex Soriano, Juan Carlos Hurtado, Carme Subirà, Berta Grau-Pujol, Alejandro Javier Krolewiecki, José Muñóz · 2020 · PLoS ONE
87. Why do COVID death rates seem to be falling?
    Heidi K. Ledford · 2020 · Nature
88. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
    Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, Babak Sharif-Kashani, Mohsen Farrokhpour, Hooman Bakhshandeh, Seyed Hashem Sezavar, Ali Dabbagh, Mohammad Taghi Beigmohammadi, Pooya Payandemehr et al. · 2020 · Thrombosis Research
89. Pediatric croup with COVID-19
    A. M. Venn, J. Schmidt, P. Mullan · 2020 · American Journal of Emergency Medicine
90. Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
    Carina Conzelmann, Janis A. Müller, Lukas Perkhofer, Konstantin M. J. Sparrer, Alexander N. Zelikin, Jan Münch, Alexander Kleger · 2020 · Clinical Medicine
91. Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study
    A. Ip, Jaeil Ahn, Yizhao Zhou et al. · 2020 · BMC Infectious Diseases
92. Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
    Umesha Naragalu Boregowda, Abhilash Perisetti, Arpitha Nanjappa, Mahesh Gajendran, Gurusaravanan Kutti Sridharan, Hemant Goyal · 2020 · Frontiers in Medicine
93. Review of Burden, Clinical Definitions, and Management of COVID-19 Cases
    Laura McArthur, Dhanasekaran Sakthivel, Ricardo Ataíde, Felicia Chan, Jack S. Richards, Charles A. Narh · 2020 · American Journal of Tropical Medicine and Hygiene
94. Ferritin as prognostic marker in COVID-19: the FerVid study
    Ombretta Para, Lorenzo Caruso, Giulia Pestelli, Flavio Tangianu, Davide Carrara, Lucia Maddaluni, Antonio Tamburello, Laura Castelnovo, G. Fedi, Stefano Guidi et al. · 2021 · Postgraduate Medicine
95. Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study*
    Charles‐Hervé Vacheron, Alain Lepape, Anne Savey, Anaïs Machut, JF Timsit, Philippe Vanhems, Quoc Viet Le, Julia Egbeola, Maelle Martin, Virginie Maxime et al. · 2021 · Critical Care Medicine
96. Melatonin effects on sleep quality and outcomes of COVID‐19 patients: An open‐label, randomized, controlled trial
    Seyed Abbas Mousavi, Keyvan Heydari, Hossein Mehravaran, Majid Saeedi, Reza Alizadeh‐Navaei, Akbar Hedayatizadeh‐Omran, Amir Shamshirian · 2021 · Journal of Medical Virology
97. A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States
    Daniel M. Sheinson, Joseph Dang, Anuj Shah, Yang Meng, David Elsea, Stacey L. Kowal · 2021 · Advances in Therapy
98. Current treatment in COVID-19 disease: a rapid review
    Miguel Antonio Rodriguez Guerra, Preeti Jadhav, Timothy J. Vittorio · 2021 · Drugs in Context
99. Repurposing drugs for the management of COVID-19
    Jacopo Cusinato, Ylenia Cau, Anna Maria Calvani, Mattia Mori · 2020 · Expert Opinion on Therapeutic Patents
100. Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease
     Zaid Zoumot, Maria-Fernanda Bonilla, Ali Saeed Wahla, Irfan Shafiq, Mateen Haider Uzbeck, Rania M. El-Lababidi, Fadi Hamed, Mohamed Abuzakouk, Mahmoud El-Kaissi · 2021 · BMC Pulmonary Medicine